Gijs van de Wetering

About

Gijs' background lies in Biomedical Engineering and Industrial Engineering. He obtained his PhD in Health Economics in 2014. Gijs is currently an Executive Director in the Modeling and Meta-analysis team at OPEN Health. He has experience managing large integrated services projects as well as more specialized projects and has a proven track record of numerous successful reimbursement submissions. Gijs’ main interests lie in solving meaningful puzzles with bright and motivated professionals, the (economic) evaluation of innovative medicines and working at the intersection between HEOR and market access. Specialties: Health economic modeling, Market access, Management & leadership

Experience

• OPEN Health (Full-time · 3 yrs 6 mos)
  • Global Head of Modeling & Meta-Analysis
    Jan 2025 - Present · 1 yr 6 mos

  • Executive Director
    Jan 2023 - Jan 2025 · 2 yrs 1 mo

• OPEN Health Evidence & Access (10 yrs)
  • Senior Director
    Jan 2021 - Jan 2023 · 2 yrs 1 mo

  • Director
    Jan 2020 - Jan 2021 · 1 yr 1 mo

  • Associate Director
    Jan 2018 - Jan 2020 · 2 yrs 1 mo

• PhD student in Health Economics at department of Epidemiology, Biostatistics and HTA at Radboud University Nijmegen Medical Centre
  Aug 2009 - Jan 2013 · 3 yrs 6 mos

  Essentially, this PhD project consists of three independent parts: Fundamental research: - Developing an algorithm to quantify short run inefficiencies not identified in conventional economic evaluations in healthcare. Applied research: - Economic evaluation of the Care- and Welfare Standard (ZWS) project involving new integrated care pathways for frail elderly people. Consultancy assignment: - Economic evaluation of the orphan drug Eculizumab (Soliris) as part of the market access procedure for the Dutch Health Care Insurance Board/Pharmaceutical Care Committee. Oral presentations: European Conference on Health Economics 2010, Helsinki. "A model to correct for short run inefficiencies in economic evaluations in health care." Lowlands Health Economists' Study Group 2011, Soesterberg. "The role of short run induced incentives in health care investment decision making." Lowlands Health Economists' Study Group 2012, Almen. "The impact of learning on economic evaluations in health care." European Conference on Health Economics 2012, Zurich. "Time to incorporate time in cost-effectiveness analysis."

• HTA researcher at department of Health Technology and Services Research at University of Twente
  Apr 2009 - Dec 2010 · 1 yr 9 mos

  Cost effectiveness analyses for new technologies in the health care sector using TreeAge software. Examples include point-of-care applications involving lab-on-a-chip technology and the evaluation of individualized breast cancer follow-up programs.

• Interim Professional at Welten
  Feb 2009 - Apr 2009 · 3 mos

  Internal optimization of business processes at Fortis Rotterdam.